What lab-grown ‘mini-brains’ are revealing about this mysterious organ
Blobs of human brain cells cultivated in the lab, known as brain organoids or “mini-brains”, are transforming our understanding of neural development and disease. Now, researchers are working to make them more like the real thing
FEATURES – Historical plagues led to revolutions – could coronavirus do the same?
FEATURES – Scott Bolton on his missions to the gas giants of the solar system
FEATURES – What lab-grown ‘mini-brains’ are revealing about this mysterious organ
The chances of mini brains becoming sentient, herd immunity, bat-like dinosaurs, and a UK government decision threatens gender diversity in academia.
In this episode:
00:59 The ethics of creating consciousness
Brain organoids, created by culturing stem cells in a petri dish, are a mainstay of neuroscience research. But as these mini-brains become more complex, is there the chance they could become conscious, and if so, how could we tell?
So called ‘herd immunity’ is claimed by some as a way to break the chain of infection and curtail the pandemic. However epidemiologists say that this course of action is ineffective and will lead to large numbers of infections and deaths.
23:22 How cutting red-tape could harm gender diversity in UK academia
The Athena SWAN scheme, designed to boost gender-equality in UK academia, has proved effective, and has been exported to countries around the world. But now a decision by the UK government to cut bureaucracy could mean that institutions pay less heed to schemes like this and threaten future efforts to increase gender diversity in UK academia.
We discuss some highlights from the Nature Briefing. This time, oncologists discover a potential new human organ, and how re-examined fossils have given new insights into the size of baby tyrannosaurs.
In this month’s episode, we learn that human brains differentiate musical pitch a way that macaque monkeys do not. In fact, speech and music shaped the human brain’s hearing circuits. Researchers are studying these circuits with an eye on developing treatments for neurological disorders.